- Home
- LSTA vs PIII Comparison
LSTA vs PIII Comparison
Compare LSTA & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LSTA | PIII |
|---|---|---|
| Founded | 1980 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4M | 13.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LSTA | PIII |
|---|---|---|
| Price | $1.95 | $3.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $23.50 | $16.25 |
| AVG Volume (30 Days) | ★ 30.2K | 12.5K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,070,000.00 | ★ $1,444,952,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.81 | $3.40 |
| 52 Week High | $4.20 | $14.50 |
Technical Indicators
Market Signals| Indicator | LSTA | PIII |
|---|---|---|
| Relative Strength Index (RSI) | 41.30 | 29.53 |
| Support Level | $1.84 | $3.47 |
| Resistance Level | $2.02 | $3.98 |
| Average True Range (ATR) | 0.11 | 0.26 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 31.39 | 12.81 |
Price Performance
Historical ComparisonAbout LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.